FDA to tighten phenobarbital, chlordiazepoxide scheduling in September
Taipei, July 15 (CNA) The Food and Drug Administration (FDA) announced Saturday that all compound drugs containing phenobarbital and chlordiazepoxide will be classed as Schedule 4 controlled substances by default under new rules set to be implemented in September.